Astria Therapeutics Inc (ATXS)
9.02
0.00 (0.00%)
USD |
NASDAQ |
May 24, 16:00
9.025
0.00 (0.00%)
After-Hours: 20:00
Astria Therapeutics Total Assets (Quarterly): 378.81M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 378.81M |
| December 31, 2023 | 254.67M |
| September 30, 2023 | 193.86M |
| June 30, 2023 | 207.05M |
| March 31, 2023 | 218.24M |
| December 31, 2022 | 230.63M |
| September 30, 2022 | 119.82M |
| June 30, 2022 | 105.29M |
| March 31, 2022 | 114.65M |
| December 31, 2021 | 127.51M |
| September 30, 2021 | 135.13M |
| June 30, 2021 | 140.94M |
| March 31, 2021 | 148.74M |
| December 31, 2020 | 47.46M |
| September 30, 2020 | 56.85M |
| June 30, 2020 | 57.09M |
| March 31, 2020 | 59.18M |
| December 31, 2019 | 41.78M |
| September 30, 2019 | 43.83M |
| Date | Value |
|---|---|
| June 30, 2019 | 48.53M |
| March 31, 2019 | 54.50M |
| December 31, 2018 | 39.17M |
| September 30, 2018 | 44.70M |
| June 30, 2018 | 50.85M |
| March 31, 2018 | 18.29M |
| December 31, 2017 | 17.90M |
| September 30, 2017 | 23.31M |
| June 30, 2017 | 30.82M |
| March 31, 2017 | 33.42M |
| December 31, 2016 | 40.21M |
| September 30, 2016 | 48.94M |
| June 30, 2016 | 44.56M |
| March 31, 2016 | 54.27M |
| December 31, 2015 | 64.17M |
| September 30, 2015 | 73.66M |
| June 30, 2015 | 82.45M |
| March 31, 2015 | 26.72M |
| December 31, 2014 | 15.96M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
41.78M
Minimum
Dec 2019
378.81M
Maximum
Mar 2024
136.50M
Average
123.67M
Median
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 11.41M |
| iBio Inc | 50.15M |
| Theriva Biologics Inc | 48.73M |
| Oragenics Inc | 3.534M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 11.07M |
| Shareholders Equity (Quarterly) | 367.74M |